Jump to: What does UK guidance say
Ros in cancer therapy: the bright side of the moon
As of 2025, it remains in Phase 3 clinical trials globally and has not received approval from the Therapeutic Goods Administration (TGA)
(I cant stop picturing a sad rodent on crutches!!) These studies show interesting things such as faster healing, reduced inflammation, improved blood vessel growth
Use the Ronin reconstitution calculator for concentration math across different reconstitution volumes
This guide compares Shotsy with Pep, a free GLP-1 tracker built specifically for people on Ozempic, Wegovy, Mounjaro, Zepbound, and oral GLP-1 medications